At this stage, administration of an MTORC1 inhibitor rapamycin for 10 weeks could restore mTOR signaling, decrease Aβ and tau pathology, and ameliorate cognitive deficits (Caccamo, Majumder, Richardson, Strong, & Oddo, 2010). Here, MAPT is linked to Cognitive impairment.